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ABSTRACT
Objective: In the present study, three different extracts of Pemna herbacea (Roxb.) were evaluated for its anticonvulsant activity against 
pentylenetetrazol (PTZ) and maximal electroshock (MES)-induced convulsions in mice.
Methods: The shed-dried powder of P. herbacea roots was passed through a sieve and subjected to extraction using Soxhlet apparatus with 70% 
ethanol, petroleum ether, and chloroform to get respective extracts named as ethanolic extract of P. herbacea, petroleum ether extract of P. herbacea, 
and chloroform extract of P. herbacea (PHC). Preliminary phytochemical analysis and acute oral toxicity study were done. Thereafter, the extracts were 
analyzed for PTZ- and MES-induced convulsions.
Results: The results revealed that PHC at the doses 200 and 400 mg/kg was effective against both, i.e., PTZ- and MES-induced convulsions. Overall 
PHC 400 mg/kg was most effective, as it significantly delayed onset of convulsions (p<0.01) and reduced % mortality (50%) in PTZ model, while in 
MES model, it showed the highest reduction in duration of hind limb extension (p<0.01) and percentage protection (33.33%).
Conclusion: The results reported anticonvulsant potential of PHC against both PTZ- and MES-induced convulsions suggesting mixed mechanism of 
action which may be attributed to different phytochemicals acting simultaneously.
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INTRODUCTION
Convulsion is one of the most common and chronic neurological disorders 
in human beings with an incidence rate of approximately 1% of the total 
population [1,2]. It is characterized by recurrent and unpredictable 
interruptions of normal brain function that is epileptic seizures [3]. The 
current therapeutic treatment of epilepsy with modern anticonvulsant 
drugs is associated with variety of side effects, dose-dependent toxicity, 
especially, on chronic administration and teratogenic effects [4-6]. 
Moreover, approximately 30% of the patients exhibit reoccurrence of 
the symptoms which is the most important concern to address [7]. This 
increasing occurrence of epilepsy is attributed to an increase in stress, 
change in lifestyle, altered food habits, excessive alcohol consumption, 
and concomitant drug administration [8,9]. Suggesting need for the 
discovery of new drug. India has one of the richest medical plant 
traditions in the world, and the traditional Indian medicinal system has 
always exemplified the phenomena of symbiosis [10]. As per literature 
survey, approximately 25,000 effective plant-based formulations used 
in folk medicine and known to rural communities in India [11,12]. The 
roots of Pemna herbacea are traditionally being used to prevent and 
control convulsions but have not been well documented scientifically. 
On the other hand, the scientific validation for its other claims such as 
analgesic, anti-inflammatory, and antiulcer [13] suggests conducting 
preclinical evaluation for scientific validation of its anticonvulsant 
potential to give newer, safer, and effective anticonvulsant drug.
MATERIALS AND METHODS
Preparation of extracts
P. herbacea (Roxb.) plant material, i.e., roots was collected from 
Southern Ghats region and authenticated by Dr. K. Madhawa Chetty at 
Sri Venkateswara University, Tirupati. These roots were shade dried 
and powdered. The powder of P. herbacea roots was passed through a 
sieve (No. 40) and subjected to extraction using Soxhlet apparatus with 
70% ethanol, petroleum ether, and chloroform at a temperature <20°C 
to get respective extracts named as ethanolic extract of P. herbacea 
(PHE) and petroleum ether extract of P. herbacea (PHP). After filtration, 
dark brown extracts were evaporated at 50°C [14].
Animal selection
Swiss albino mice (18–25g) of either sex were procured from M/s. 
National Toxicological Center, Pune. The mice were housed separately 
in the animal house and were fed on a standard pellet diet and provided 
water ad libitum. After approval of the Institutional Animal Ethics 
Committee from the National Toxicology Center, Pune, the studies were 
performed.
Drugs and chemicals
Pentylenetetrazol, Sigma, St. Louis, USA, diazepam Ranbaxy, India, and 
phenytoin sodium, M. J. Pharmaceuticals, Gujarat.
These drugs and chemical were purchased from local vendor.
Statistical analysis and calculations
Data were expressed as mean±standard error of the mean and 
statistically analyzed using one-way analysis of variance followed by 
Tukey–Kramer multiple comparisons test.
Methods
Preliminary phytochemical analysis
Preliminary phytochemical analysis was carried out using established 
methods to record the presence of phytochemicals [15].
Determination of acute toxicity study (LD50)
The acute toxicity of the extracts (PHE, PHP, and chloroform extract of 
P. herbacea [PHC]) was performed using albino mice as per the OECD 
guideline no 423 [16].
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Antiepileptic activity of PHE, PHP, and PHC on pentylenetetrazol 
(PTZ)-induced convulsions
The 66 pre-selected mice of either sex (18–22 g) were divided into 
eleven groups each consisting six mice. All these mice were subjected 
to respective treatment as mentioned in Table 1, for the period of 
7 days. On the 7th day 60 min after dosing, all mice were subjected 
to intraperitoneal injection of PTZ (80 mg/kg), and the onset of 
convulsions with percentage of mortality of mice were recorded and 
compared against vehicle-treated control mice. Diazepam (5 mg/kg) 
was used as a reference standard [17,18].
Antiepileptic activity of PHE, PHP, and PHC on maximal 
electroshock-induced convulsions
The 66 pre-selected mice of either sex (18–22 g) were divided into 
eleven groups each consisting six mice. All these mice were subjected 
to respective treatment as mentioned in Table 2, for the period of 7 
days. On the 7th day 60 min after dosing, all mice were subjected to 
maximal electroshock treatment (40 mA for 0.2 s) and the reduction 
in duration of hind limb extension(the mice showing extension <10 s) 
was considered as protected as well as percent protection of mice was 
recorded and compared against vehicle-treated control mice. Diazepam 
(5 mg/kg) was used as a reference standard [19-21].
RESULTS
Preliminary phytochemical screening of the extracts showed the 
prominent presence of phenolic components, steroids, tannins, and 
glycosides (Table 3).
The acute oral toxicity study revealed that all the three extracts 
100, 200, and 400 mg/kg were safe when administered until the 
dose of 2000 mg/kg. Based on pilot study and previously published 
papers, three doses, i.e., 100, 200, and 400 mg/kg were selected for 
anticonvulsant study [22].
In the PTZ model, the mice treated with PHE 400 mg/kg and PHP 
400 mg/kg significantly delayed the onset of convulsions and were 
found to be equipotent (p<0.05), whereas PHC 200 mg/kg and 
400 mg/kg were more significant (p<0.01) in this regard. Similar 
results were obtained for percentage mortality. PHC 400 mg/kg extract 
was the most effective test dose in this regard.
DISCUSSION
Medicinal plants are moving from fringe to mainstream use with a 
greater number of people seeking remedies and health approaches 
with lesser side effects caused by synthetic chemicals. Recently, 
considerable attention has been paid to utilize eco-friendly and bio-
friendly plant-based products for the prevention and cure of different 
human diseases [23]. Considering the adverse effects of synthetic 
drugs, the world’s population is looking for natural remedies which are 
comparatively safer and equally effective [24-26]. It is documented that 
about 80% of the world’s population has faith in traditional medicine, 
particularly plant-based drugs for their primary health care [27].
Plants consist of numerous constituents called phytochemicals with 
diverse medicinal values. Moreover, the claims made in the traditional 
literature are vague [28]. Hence, scientific validation of these claims 
is vital to make therapy more effective and patient-friendly. The 
present study has been conducted to coordinate the traditional claim, 
experimental observations, and role of phytochemicals to establish its 
close relationship toward the actual therapeutic outcome [28-30]. In 
the present investigation, preliminary phytochemical analysis of PHE 
showed the presence of glycosides, flavonoids, tannins, and steroids, 
while petroleum ether extract showed the presence of steroids Tannins. 
Steroids, anthraquinone, and coumarin glycosides were found in 
chloroform extract. The earlier scientific studies have revealed that 
these phytochemicals are chiefly responsible for the pharmacological 
actions [29-31] and thereby suggested worth to explore the traditional 
claims [32]. Toxicity is one of the most important aspects of any 
medication to govern the extent of therapeutic utility. Since preliminary 
phytochemical results gave indication of further pharmacological 
Table 1: Effects of PHE, PHP, and PHC on PTZ-induced 
convulsions




I Distilled water 10 ml/kg 247.06±1.15 100
II Diazepam 5 mg/kg 485.86±2.66 0.00
III PHE 100 mg/kg 245.18±1.22 83.33
IV PHE 200 mg/kg 244.47±1.49 83.33
V PHE 400 mg/kg 253.93±1.47* 66.66
VI PHP 100 mg/kg 246.98±1.31 100
VII PHP 200 mg/kg 247.41±0.87 83.33
VIII PHP 400 mg/kg 246.51±2.01* 83.33
IX PHC 100 mg/kg 248.96±1.12 100
X PHC 200 mg/kg 257.34±0.86** 66.66
XI PHC 400 mg/kg 261.87±1.34** 50.00
(*p<0.05, **p<0.01). The values are represented as mean±SEM (n=6). 
SEM: Standard error of the mean. In maximal electroshock MES-induced 
convulsions, PHE 400 mg/kg and PHP 400 mg/kg were found to be equally 
significant (p<0.05) to reduce the hind limb extension phase, whereas PHC 200 
mg/kg and 400 mg/kg showed dose-dependent action (p<0.05 and P<0.01) 
in this regard. On the other hand, PHC 400 mg/kg dose only showed 33.33% 
protection, and rest all doses of extracts were ineffective. PHE: Ethanolic extract 
of P. herbacea, PHP: Petroleum ether extract of P. herbacea, PHC: Chloroform 
extract of P. herbacea
Table 2: Effect of PHE, PHP, and PHC in MES convulsion. The 
values are represented as mean±SEM (n=6)
Groups Treatment Reduction 
in hind limb 
extensor
% Recovery
I Distilled water 10 ml/kg 26.18±1.26 0
II Phenytoin 25 mg/kg 07.84±1.80 83.33
III PHE 100 mg/kg 26.57±1.73 0
IV PHE 200 mg/kg 25.99±1.47 0
V PHE 400 mg/kg 22.85±1.46* 0
VI PHP 100 mg/kg 27.30±1.48 0
VII PHP 200 mg/kg 26.17±1.42 0
VIII PHP 400 mg/kg 22.42±1.98** 0
IX PHC 100 mg/kg 25.99±2.20 0
X PHC 200 mg/kg 22.74±0.91* 0
XI PHC 400 mg/kg 13.64±3.63** 33.33
(*p<0.05, **p<0.01). SEM: Standard error of the mean. The reference standard 
phonytoin was most effective in both these parameters. PHE: Ethanolic extract 
of P. herbacea, PHP: Petroleum ether extract of P. herbacea, PHC: Chloroform 
extract of P. herbacea
Table 3: Preliminary phytochemical analysis
Phytochemical PHC PHP PHE
Carbohydrates Carbohydrates ++ - -
Protein + - -
Amino acids - - -
Fats and oils - - -
Steroids + + +
Volatile oils - - -
Cardiac glycosides + - -
Anthraquinone glycosides - - -
Cyanogenetic glycosides - - -
Coumarin glycosides + - -
Saponins + - -
Flavonoids - - -
Alkaloids - - -
Tannins and phenolic compounds + + +
PHE: Ethanolic extract of P. herbacea, PHP: Petroleum ether extract of 
P. herbacea, PHC: Chloroform extract of P. herbacea
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screening, it becomes mandatory to evaluate these extracts for their 
toxicity profile and confirm its safety [33]. As per the principles of 
general pharmacology, drug shall not only be pharmacologically 
effective but also free of toxicity or else its undesirable effect shall be 
within acceptable range. The maintenance of desirable risk and benefit 
ratio is prerequisite to label any compound as a drug [34]. The acute 
oral toxicity studies of PHE, PHP, and PHC of P. herbacea revealed that 
all these extracts were found to be safe up to the dose of 2000 mg/kg. 
The results of acute oral toxicity study suggested that these extracts can 
be screened preclinically for validation of its claim in accordance with 
the methods mentioned in previously published reports. Further, the 
pilot study and dose range were found to be effective without any toxic 
outcome in earlier published reports, and three different doses, i.e., 100, 
200, and 400 mg/kg for each extract were selected for anticonvulsant 
activity [35,36]. Though the PTZ model of all three dose have reported 
significant anticonvulsant activity, overall PHC was found to be more 
effective. The PTZ induces convulsions through inhibition of gamma-
aminobutyric acid (GABA) transmission which resembles petit mal type 
of epilepsy in humans [37], and hence, this extract suggested GABA 
potentiating as a possible mechanism of action. For the petit mal type 
of epilepsy delayed onset, reduction in duration ultimately leading to 
prevent serious outcomes such as mortality is prime objective. The PHC 
at both the doses, i.e., 200 mg/kg and 400 mg/kg showed significant 
improvement in the onset of convulsions and mortality. The prevention 
of mortality is the most important outcome of this study as it provides 
chance to manage the recurrence in more better manner. In MES-
induced convulsions, highest doses of all extract were effective, but the 
level of significance was more with PHC 400 mg/kg. In addition, PHC 
200 mg/kg was also endorsing effective suggested it as a most potent 
extract.
The MES induces convulsions chiefly by the inhibition of Na+ channels 
and represents human grand mal type epilepsy. The current results 
indicated activation of sodium channels by the extract. The PHC showed 
effectiveness in both the models which may be due to the presence of 
more than one active phytochemical acting simultaneously. The exact 
role of these phytochemicals will be revealed on further detailed 
investigation; however, it is very much clear that the extract has 
potential to act in a mixed type of epilepsy for which modern medicine 
has limitation.
CONCLUSION
The chloroform extract of the root of P. herbacea showed significant 
anticonvulsant activity against both PTZ- and MES-induced convulsions 
and thereby validated its traditional claim. The study also suggested 
a mixed mechanism of action which may be attributed to different 
phytochemicals acting simultaneously.
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